Publications in collaboration with researchers from Academic Medical Center (4)

2022

  1. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

    The Lancet Infectious Diseases, Vol. 22, Núm. 3, pp. 329-340

2019

  1. Rational Design, Structure–Activity Relationship, and Immunogenicity of Hypoallergenic Pru p 3 Variants

    Molecular Nutrition and Food Research, Vol. 63, Núm. 18

2015

  1. Development of a hypoallergenic recombinant parvalbumin for first-in-man subcutaneous immunotherapy of fish allergy

    International Archives of Allergy and Immunology, Vol. 166, Núm. 1, pp. 41-51

2012

  1. Fast: Towards safe and effective subcutaneous immunotherapy of persistent life-threatening food allergies

    Clinical and Translational Allergy, Vol. 2, Núm. 1